Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Seeks Preliminary Injunction Against Teva/Sun Barring Protonix Generics

This article was originally published in The Pink Sheet Daily

Executive Summary

Final ANDA approval of Teva's and Sun’s generic versions of the proton pump inhibitor are anticipated in August and September, respectively.

You may also be interested in...



Protonix Generics Could Be Imminent After Denial Of Wyeth’s Preliminary Injunction Request

New Jersey district court denies request to bar launch of generic pantoprazole.

Protonix Generics Could Be Imminent After Denial Of Wyeth’s Preliminary Injunction Request

New Jersey district court denies request to bar launch of generic pantoprazole.

Wyeth Seeks To Consolidate Protonix Patent Cases

Teva, Sun Pharmaceutical and Schwarz Pharma targeted in lawsuits involving the proton pump inhibitor.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS066233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel